Skip to content
Study details
Enrolling now

Brain-Controlled Spinal Stimulation Walking Therapy After Incomplete Spinal Cord Injury (SCI)

University of Miami
NCT IDNCT06406855ClinicalTrials.gov data as of Apr 2026
Target enrollment

12

Study length

about 2.7 years

Ages

18–70

Locations

1 site in FL

What this study is about

This trial is testing a new therapy called Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS) to see if it helps people with incomplete spinal cord injury walk better. The treatment will last for 968 days.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.BCI-TSCS

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Number of treatment related incidence of adverse events (AEs), Walking function using 6 minute walk test (6MWT)

Secondary: Quality of Life measured by the Reintegration to Normal Living (RNL) questionnaires, Quality of Life using the International Spinal Cord Injury - Quality of Life (ISCI-QOL)

Body systems

Neurology